Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
- 18 June 2007
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 99 (12), S34-S43
- https://doi.org/10.1016/j.amjcard.2007.03.004
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in NorfolkAnnals of Internal Medicine, 2004
- Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes MellitusAnnals of Internal Medicine, 2004
- Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk FactorAnnals of Internal Medicine, 2004
- Is the Current Definition for Diabetes Relevant to Mortality Risk From All Causes and Cardiovascular and Noncardiovascular Diseases?Diabetes Care, 2003
- Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)BMJ, 2001
- Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ, 2000
- The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.Diabetes Care, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Cardiovascular Events and Correlates in the Veterans Affairs Diabetes Feasibility TrialArchives of Internal Medicine, 1997
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993